LD-2 disclosure · 3rd Quarter - Report
CENCORA, INC.
via CENCORA, INC.
Client
- Name
- CENCORA, INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- CENCORA, INC.
- Description
- Pharmaceutical Distributor
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
4 issuesTaxation/Internal Revenue Code
One Big Beautiful Bill Act/Budget Reconciliation (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)
LobbyistsVIVIENNE STAFFORD MITCHELL · SHELLY MUI-LIPNIK · DARRELL ROGERS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). CMS Proposed Medicare Physician Fee Schedule Rule Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages
LobbyistsVIVIENNE STAFFORD MITCHELL · SHELLY MUI-LIPNIK · DARRELL ROGERS
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Centers For Medicare and Medicaid Services (CMS)
Pharmacy
Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426)- Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA)
